Berkshire Bank’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
AIM
FWIA
DLA
ETC
Berkshire Bank's BMY Position: Q2 2026 in Review
Berkshire Bank sold out of Bristol-Myers Squibb (BMY) in Q2 2026, closing a stake of 4,026 shares — an estimated $244K sold.
Berkshire Bank first reported a position in BMY in Q3 2020 and held it in 23 quarters. The position peaked at $3.51M in Q2 2021. 832 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Berkshire Bank reported no remaining Bristol-Myers Squibb position as of Q2 2026 after selling out during the quarter.
- Berkshire Bank sold 4,026 Bristol-Myers Squibb shares in Q2 2026, an estimated $244K.
- Berkshire Bank first reported a position in Bristol-Myers Squibb in Q3 2020 and held it in 23 quarters.
- Berkshire Bank's Bristol-Myers Squibb position peaked at $3.51M in Q2 2021.
- 832 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Berkshire Bank's 13F filing for Q2 2026, filed 8 Jul 2026.